In silico antiprotozoal evaluation of 1, 4-naphthoquinone derivatives against chagas and leishmaniasis diseases using QSAR, molecular docking, and ADME …

LS Prieto Cárdenas, KA Arias Soler… - Pharmaceuticals, 2022 - mdpi.com
Chagas and leishmaniasis are two neglected diseases considered as public health
problems worldwide, for which there is no effective, low-cost, and low-toxicity treatment for …

[HTML][HTML] Acoplamiento molecular de la interacción de imidazoles 4, 5-fenil y 4, 5-furilsustituidos con enzimas Cyp51 de T. Cruzi, T. Brucei y L. Infantum

M Castro-Piñol, A García-López, JR Vargas… - Revista Cubana de …, 2022 - scielo.sld.cu
RESUMEN Las subespecies Leishmania spp., Trypanosoma cruzi y Trypanosoma brucei
son los agentes causantes de la leishmaniasis, la tripanosomiasis americana y la …